封面
市场调查报告书
商品编码
1601185

药品无菌转移市场:依产品、技术、系统类型、可用​​性、灭菌方法、最终用途、应用 - 2025-2030 年全球预测

Pharmaceutical Aseptic Transfer Market by Product, Technology, System Type, Usability, Sterilization Method, End-use, Application - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品无菌转移市场价值为14.4亿美元,预计到2024年将达到15.6亿美元,复合年增长率为8.26%,到2030年将达到25.1亿美元。

药品无菌转移市场涉及物质在无菌环境中的安全转移和无污染的转移。该过程在製药行业中对于保持药物的纯度和有效性极为重要,特别是在製造过程中。无菌运输的需求在于其能够防止污染并确保产品完整性,并且在註射剂、生技药品和疫苗等无菌药品的生产中发挥关键作用。应用范围涵盖药品製造、生物技术和研究实验室,最终用途包括製造设施、研发实验室和复方药房。影响该市场的成长要素包括对生技药品和生物相似药的需求不断增加、药品生产中对无菌的严格监管要求以及无菌运输技术的进步。一次性系统和自动化解决方案的开发可以提高效率并降低污染风险,从而带来新的商机。企业应探索灵活运输系统的创新和物联网的集成,以加强监控。市场限制包括建立无菌设施的初始投资较高以及遵守不断变化的监管标准的复杂性。此外,缺乏熟练劳动力以及操作先进系统的潜在技术故障可能是一个挑战。为了利用成长机会,公司应专注于研究和开发新的灭菌方法和先进材料,在确保无菌的同时提供易用性。建议与监管机构合作并投资培训计划,以克服营运挑战。该市场的特点是众多大大小小的参与者之间竞争激烈,强调需要透过创新和品质改进实现差异化。此外,对永续和环保实践的坚定承诺可以与不断提高的环境意识和永续性法规相一致,并提高竞争力。

主要市场统计
基准年[2023] 14.4亿美元
预测年份 [2024] 15.6亿美元
预测年份 [2030] 25.1亿美元
复合年增长率(%) 8.26%

市场动态:快速发展的药品无菌转移市场的关键市场洞察

供需的动态交互作用正在改变药品无菌转移市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 製药和生物製药生产活动的增加
    • 存在有关药品安全和品质的严格监管标准
  • 市场限制因素
    • 药品无菌传输系统的製造成本高
  • 市场机会
    • 策略性投资加强契约製造的无菌能力
    • 一次性药物无菌转移系统的趋势日益明显
  • 市场挑战
    • 药品无菌传输系统的性能问题

波特五力:驾驭药品无菌转移市场的策略工具

波特的五力架构是了解药品无菌转移市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解药品无菌转移市场的外部影响

外部宏观环境因素在塑造药品无菌转移市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析:了解药品无菌转移市场的竞争格局

对药品无菌转移市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵:药品无菌转移市场供应商的绩效评估

FPNV 定位矩阵是评估药品无菌转移市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议:制定药品无菌转移市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对药品无菌转移市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药和生物製药生产活动的增加
      • 存在有关药品安全和品质的严格监管标准
    • 抑制因素
      • 药品无菌传输系统的製造成本较高
    • 机会
      • 契约製造製造商策略投资,强化无菌操作能力
      • 一次性药物无菌转移系统的成长趋势
    • 任务
      • 製药无菌传输系统的具体性能问题
  • 市场区隔分析
    • 产品:快速推出无菌运输隔离器,显着确保无菌性
    • 技术:大力引进自动化无菌输送系统,方便大量生产
    • 系统类型:越来越多地采用液体传输系统来适应各种批量大小和配方业务。
    • 可用性:多用途系统的使用正在迅速增加,因为从长远来看它们具有成本效益。
    • 灭菌方法:蒸气灭菌的使用正在迅速增加,并且由于其广泛的有效性和效率而成为首选。
    • 最终用途:製药公司越来越多地使用药品无菌传输系统
    • 应用:在药物开发和药物发现中越来越关注无菌药物运输
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品无菌转移市场:副产品

  • 无菌灌装/精加工设备
  • 无菌取样系统
  • 无菌运输隔离器
  • 无菌输送帮浦
  • 无菌转移无菌袋
  • 手套口和袖子

第七章药品无菌转移市场:依技术分类

  • 自动无菌输送系统
  • 手动无菌转移装置

第八章依系统类型分類的药品无菌转移市场

  • 液体输送系统
  • 固体传输系统

第九章药品无菌转移市场:依可用性

  • 多用途
  • 一次性的

第十章 依灭菌方法分类的药品无菌转运市场

  • 环氧乙烷 (EtO) 灭菌
  • 过滤除菌
  • 伽玛射线照射
  • 蒸气灭菌

第十一章药品无菌转移市场:依最终用途

  • 生技公司
  • 合约开发和製造组织
  • 医院/诊所
  • 製药公司

第十二章药品无菌转移市场:依应用分类

  • 生物安全和品管
  • 临床诊断
  • 药物开发和药物发现
  • 无菌测试

第十三章:美洲药品无菌转移市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太药品无菌转移市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲药品无菌转移市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • ChargePoint Technology 在印度设立子公司,提供先进的无菌转移解决方案
    • ChargePoint Technology 推出用于无菌输送的机器人物料输送方案
    • Bora Pharmaceuticals 从 Emergent BioSolutions 收购巴尔的摩製造工厂
    • Syntegon 推出自动沉淀换板装置以增强无菌生产
    • Syntegon 收购 Telstar 以增强无菌药物转移能力
    • AGC Biologics 与 BioConnection 合作加强生物製药开发和製造
    • ChargePoint 扩大了药品无菌转移产品阵容
    • Gemini Bioproducts 推出最先进的无菌保证系统
    • Argonaut 融资 4,500 万美元用于扩大无菌灌装和精加工能力
    • Flexicon 液体填充和 Franz Ziel GmbH 推出 Cellefill
    • Sevar Pharma Solutions 扩大高效注射剂的无菌填充能力
    • 塔科马无菌实验室和自动化系统合作彻底改变无菌药物转移技术
  • 战略分析和建议
    • 库斯塔斯有限公司
    • 赛多利斯公司
    • 赛默飞世尔科技有限公司
    • 默克
    • 城巴

公司名单

  • ABC Transfer SAS
  • AdvantaPure by NewAge Industries
  • Atec Pharmatechnik GmbH
  • castus GmbH & Co. KG
  • Catalent, Inc.
  • Central Research Laboratories by Dover Corporation
  • Chargepoint Technology Limited
  • Comecer SpA by ATS Corporation
  • Cytiva by Danaher Corporation
  • Ecolab Inc.
  • Entegris, Inc.
  • Ezi-Dock Systems Limited
  • Fedegari Autoclavi SpA
  • Flexifill Ltd.
  • Germfree Laboratories, Inc.
  • Getinge AB
  • ILC Dover LP by Ingersoll Rand Inc.
  • IMA SpA
  • JCE BIOTECHNOLOGY SAS
  • Merck KGaA
  • OPTIMA Packaging Group GmbH
  • Sartorius AG
  • SKAN Group AG
  • Steriline Srl
  • Syntegon Technology GmbH
  • Tema Sinergie SpA
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
Product Code: MRR-5C6F41F5B03C

The Pharmaceutical Aseptic Transfer Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.56 billion in 2024, and is projected to grow at a CAGR of 8.26%, to USD 2.51 billion by 2030.

The pharmaceutical aseptic transfer market involves the safe and sterile transfer of materials into or out of a sterile environment without contamination. This process is crucial in the pharmaceutical industry to maintain the purity and efficacy of drugs, especially during manufacturing processes. The necessity of aseptic transfer lies in its ability to prevent contamination and ensure product integrity, playing a vital role in the production of sterile pharmaceuticals such as injectables, biologics, and vaccines. Applications span across pharmaceutical manufacturing, biotechnology, and research laboratories, with end-use sectors including manufacturing facilities, R&D labs, and compounding pharmacies. Growth factors influencing this market include increasing demand for biologics and biosimilars, stringent regulatory requirements for sterility in pharmaceutical production, and advancements in aseptic transfer technologies. Emerging opportunities arise from developments in single-use systems and automation solutions, which can enhance efficiency and reduce contamination risks. Companies should explore innovations in flexible transfer systems and integration of IoT for enhanced monitoring and control. Market limitations include high initial investments for setting up aseptic facilities and the complexity of compliance with evolving regulatory standards. Additionally, the lack of skilled workforce to operate advanced systems and potential technological failures can pose challenges. To leverage growth opportunities, businesses should focus on research and development in novel sterilization methods and advanced materials that ensure sterility yet offer ease of use. Collaborations with regulatory bodies and investment in training programs are recommended to overcome operational challenges. The market is characterized by intense competition with numerous small and large players, emphasizing the need for differentiation through innovation and quality improvement. A keen focus on sustainable and eco-friendly practices can also offer a competitive edge, aligning with growing environmental awareness and regulatory emphasis on sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.56 billion
Forecast Year [2030] USD 2.51 billion
CAGR (%) 8.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Aseptic Transfer Market

The Pharmaceutical Aseptic Transfer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising pharmaceutical and biopharmaceutical production activities
    • Availability of strict regulatory standards for drug safety and quality
  • Market Restraints
    • High cost of manufacturing of pharmaceutical aseptic transfer system
  • Market Opportunities
    • Strategic investments by contract manufacturers to enhance aseptic operation capabilities
    • Increasing inclination toward single-use pharmaceutical aseptic transfer system
  • Market Challenges
    • Certain performance issues with pharmaceutical aseptic transfer system

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Aseptic Transfer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Aseptic Transfer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Aseptic Transfer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Aseptic Transfer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Aseptic Transfer Market

A detailed market share analysis in the Pharmaceutical Aseptic Transfer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Aseptic Transfer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Aseptic Transfer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Aseptic Transfer Market

A strategic analysis of the Pharmaceutical Aseptic Transfer Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Aseptic Transfer Market, highlighting leading vendors and their innovative profiles. These include ABC Transfer SAS, AdvantaPure by NewAge Industries, Atec Pharmatechnik GmbH, castus GmbH & Co. KG, Catalent, Inc., Central Research Laboratories by Dover Corporation, Chargepoint Technology Limited, Comecer S.p.A. by ATS Corporation, Cytiva by Danaher Corporation, Ecolab Inc., Entegris, Inc., Ezi-Dock Systems Limited, Fedegari Autoclavi S.p.A., Flexifill Ltd., Germfree Laboratories, Inc., Getinge AB, ILC Dover LP by Ingersoll Rand Inc., IMA S.p.A., JCE BIOTECHNOLOGY SAS, Merck KGaA, OPTIMA Packaging Group GmbH, Sartorius AG, SKAN Group AG, Steriline S.r.l., Syntegon Technology GmbH, Tema Sinergie S.p.A., Thermo Fisher Scientific Inc., and Watson-Marlow Fluid Technology Solutions by Spirax Group PLC.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Aseptic Transfer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aseptic Fill/Finish Equipment, Aseptic Sampling Systems, Aseptic Transfer Isolators, Aseptic Transfer Pumps, Aseptic Transfer Sterile Bags, and Glove Ports & Sleeves.
  • Based on Technology, market is studied across Automated Aseptic Transfer Systems and Manual Aseptic Transfer Devices.
  • Based on System Type, market is studied across Liquid Transfer System and Solid Transfer System.
  • Based on Usability, market is studied across Multiple-Use and Single-Use.
  • Based on Sterilization Method, market is studied across Ethylene Oxide (EtO) Sterilization, Filtration Sterilization, Gamma Irradiation, and Steam Sterilization.
  • Based on End-use, market is studied across Biotechnology Firms, Contract Development & Manufacturing Organizations, Hospitals & Clinics, and Pharmaceutical Companies.
  • Based on Application, market is studied across Biosafety & Quality Control, Clinical Diagnostics, Drug Development & Drug Discovery, and Sterility Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising pharmaceutical and biopharmaceutical production activities
      • 5.1.1.2. Availability of strict regulatory standards for drug safety and quality
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing of pharmaceutical aseptic transfer system
    • 5.1.3. Opportunities
      • 5.1.3.1. Strategic investments by contract manufacturers to enhance aseptic operation capabilities
      • 5.1.3.2. Increasing inclination toward single-use pharmaceutical aseptic transfer system
    • 5.1.4. Challenges
      • 5.1.4.1. Certain performance issues with pharmaceutical aseptic transfer system
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Exponential adoption of aseptic transfer isolators providing significant sterility assurance
    • 5.2.2. Technology: Significant adoption of the automated aseptic transfer systems useful for high production volumes
    • 5.2.3. System Type: Rising adoption of liquid transfer systems caters to operations with diverse batch sizes and formulations
    • 5.2.4. Usability: Proliferating use of multiple-use systems owing to their cost-efficiency in the long term
    • 5.2.5. Sterilization Method: Burgeoning utilization of steam sterilization, preferred for its broad-spectrum efficacy and efficiency
    • 5.2.6. End-use: Increasing use of pharmaceutical aseptic transfer systems across pharmaceutical companies
    • 5.2.7. Application: Growing focus on pharmaceutical aseptic transfer for drug development and drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Aseptic Transfer Market, by Product

  • 6.1. Introduction
  • 6.2. Aseptic Fill/Finish Equipment
  • 6.3. Aseptic Sampling Systems
  • 6.4. Aseptic Transfer Isolators
  • 6.5. Aseptic Transfer Pumps
  • 6.6. Aseptic Transfer Sterile Bags
  • 6.7. Glove Ports & Sleeves

7. Pharmaceutical Aseptic Transfer Market, by Technology

  • 7.1. Introduction
  • 7.2. Automated Aseptic Transfer Systems
  • 7.3. Manual Aseptic Transfer Devices

8. Pharmaceutical Aseptic Transfer Market, by System Type

  • 8.1. Introduction
  • 8.2. Liquid Transfer System
  • 8.3. Solid Transfer System

9. Pharmaceutical Aseptic Transfer Market, by Usability

  • 9.1. Introduction
  • 9.2. Multiple-Use
  • 9.3. Single-Use

10. Pharmaceutical Aseptic Transfer Market, by Sterilization Method

  • 10.1. Introduction
  • 10.2. Ethylene Oxide (EtO) Sterilization
  • 10.3. Filtration Sterilization
  • 10.4. Gamma Irradiation
  • 10.5. Steam Sterilization

11. Pharmaceutical Aseptic Transfer Market, by End-use

  • 11.1. Introduction
  • 11.2. Biotechnology Firms
  • 11.3. Contract Development & Manufacturing Organizations
  • 11.4. Hospitals & Clinics
  • 11.5. Pharmaceutical Companies

12. Pharmaceutical Aseptic Transfer Market, by Application

  • 12.1. Introduction
  • 12.2. Biosafety & Quality Control
  • 12.3. Clinical Diagnostics
  • 12.4. Drug Development & Drug Discovery
  • 12.5. Sterility Testing

13. Americas Pharmaceutical Aseptic Transfer Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Pharmaceutical Aseptic Transfer Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Pharmaceutical Aseptic Transfer Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. ChargePoint Technology launches subsidiary in India for advanced aseptic transfer solutions
    • 16.3.2. ChargePoint Technology unveils robotic material handling solution for aseptic transfer
    • 16.3.3. Bora Pharmaceuticals acquires Baltimore manufacturing facility from Emergent BioSolutions
    • 16.3.4. Syntegon unveils automated settle plate changer for enhanced aseptic manufacturing
    • 16.3.5. Syntegon acquires Telstar to strengthen pharmaceutical aseptic transfer capabilities
    • 16.3.6. AGC Biologics and BioConnection partner for enhanced biopharma drug development and manufacturing
    • 16.3.7. ChargePoint to expand pharmaceutical aseptic transfer product range
    • 16.3.8. Gemini Bioproducts launches cutting-edge aseptic assurance system
    • 16.3.9. Argonaut raises USD 45 Million to enhance aseptic fill/finish capabilities
    • 16.3.10. Flexicon Liquid Filling and Franz Ziel GmbH launched Cellefill
    • 16.3.11. Sever Pharma Solutions expands aseptic filling capacity for high-potency injectables
    • 16.3.12. Germfree Laboratories and Automated Systems of Tacoma collaborate to innovate pharmaceutical aseptic transfer technology
  • 16.4. Strategy Analysis & Recommendation
    • 16.4.1. Castus GmbH & Co.KG
    • 16.4.2. Sartorius AG
    • 16.4.3. Thermo Fisher Scientific Inc.
    • 16.4.4. Merck KGaA
    • 16.4.5. Cytiva

Companies Mentioned

  • 1. ABC Transfer SAS
  • 2. AdvantaPure by NewAge Industries
  • 3. Atec Pharmatechnik GmbH
  • 4. castus GmbH & Co. KG
  • 5. Catalent, Inc.
  • 6. Central Research Laboratories by Dover Corporation
  • 7. Chargepoint Technology Limited
  • 8. Comecer S.p.A. by ATS Corporation
  • 9. Cytiva by Danaher Corporation
  • 10. Ecolab Inc.
  • 11. Entegris, Inc.
  • 12. Ezi-Dock Systems Limited
  • 13. Fedegari Autoclavi S.p.A.
  • 14. Flexifill Ltd.
  • 15. Germfree Laboratories, Inc.
  • 16. Getinge AB
  • 17. ILC Dover LP by Ingersoll Rand Inc.
  • 18. IMA S.p.A.
  • 19. JCE BIOTECHNOLOGY SAS
  • 20. Merck KGaA
  • 21. OPTIMA Packaging Group GmbH
  • 22. Sartorius AG
  • 23. SKAN Group AG
  • 24. Steriline S.r.l.
  • 25. Syntegon Technology GmbH
  • 26. Tema Sinergie S.p.A.
  • 27. Thermo Fisher Scientific Inc.
  • 28. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL ASEPTIC TRANSFER MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. PHARMACEUTICAL ASEPTIC TRANSFER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL ASEPTIC TRANSFER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL ASEPTIC TRANSFER MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC FILL/FINISH EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC SAMPLING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER ISOLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ASEPTIC TRANSFER STERILE BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY GLOVE PORTS & SLEEVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY AUTOMATED ASEPTIC TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY MANUAL ASEPTIC TRANSFER DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY LIQUID TRANSFER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SOLID TRANSFER SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY MULTIPLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY ETHYLENE OXIDE (ETO) STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY BIOSAFETY & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY DRUG DEVELOPMENT & DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY PHARMACEUTICAL ASEPTIC TRANSFER MARKET SIZE, BY SYSTEM TYPE, 2018-2030